P19 embryonal carcinoma cells: a new model for the study of endothelial cell differentiation

Biotechnol Lett. 2008 Jul;30(7):1169-75. doi: 10.1007/s10529-008-9677-6. Epub 2008 Mar 4.

Abstract

P19 embryonal carcinoma cells were examined under different conditions of embryoid body (EB) formation to evaluate endothelial differentiation. A prominent capillary-like network including PECAM-1 positive cells and upregulated expression of endothelial markers Tie-1, Tie-2, Flk-1 and PECAM-1 were identified in the DMSO-treated group during EB formation as well as after VEGF treatment. About 4% of the P19 cells differentiated into PECAM-1 positive cells on day 14 of differentiation. These results suggest that the P19 cells have the potential for endothelial cell differentiation and provide a new model system for future research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation / biosynthesis*
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • Cryoprotective Agents / pharmacology
  • Dimethyl Sulfoxide / pharmacology
  • Embryonal Carcinoma Stem Cells / cytology
  • Embryonal Carcinoma Stem Cells / metabolism*
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Mice
  • Models, Biological*

Substances

  • Antigens, Differentiation
  • Cryoprotective Agents
  • Dimethyl Sulfoxide